ClinicalTrials.gg
Drug

Bortezomib clinical trials

Also written Velcade, LDP 341 and MLN341.

studies test it
651
open now
39
in phase 3
65
first study started
1999
Related medicines add 4 studies

Counted the way a researcher would: Bortezomib with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Bortezomib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bortezomib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
13 May 2003 · VELCADE · NDA 021602 (FDA, Drugs@FDA)
European Union
26 Apr 2004 · Velcade · EMEA/H/C/000539 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bortezomib
499
[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
23
Bortezomib (Velcade)
9
Bortezomib Injection
8
Velcade (bortezomib)
7

Brand

Velcade
341

Development codes

LDP 341
106
MLN341
106
PS-341
68

In one entry with another drug

Given together, or one or the other

Lenalidomide, Bortezomib
3
bortezomib + rituximab
2

Studies by the year they started

643 studies that test it; most in 2006 (69)

Studies that test Bortezomib, by start year
YearStudies
19992
20003
200118
200213
200320
200442
200563
200669
200740
200847
200940
201047
201128
201223
201329
201416
201516
201620
201714
20189
201915
202011
202113
202213
202311
202411
20252
20268

Who runs them

Industry 83 · Other 568

National Cancer Institute (NCI) (70) · M.D. Anderson Cancer Center (26) · Millennium Pharmaceuticals, Inc. (24) · University of Arkansas (15) · Dana-Farber Cancer Institute (14) · Mayo Clinic (13) · Memorial Sloan Kettering Cancer Center (12) · Janssen Research & Development, LLC (8)

Often tested with

Tested in the same studies.

Dexamethasone (154) · Rituximab (60) · Lenalidomide (57) · Cyclophosphamide (56) · Doxorubicin (43) · Melphalan (30) · Thalidomide (27) · Daratumumab (25)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 19 phase 3 studies under way

Bortezomib is the comparator. A study of two new drugs counts under both.

  • 3Daratumumab · PETHEMA Foundation, Pfizer · next primary completion Oct 2030
  • 2Teclistamab · Janssen Research & Development, LLC, University of Heidelberg Medical Center · next primary completion Feb 2031
  • 2Belantamab mafodotin · GlaxoSmithKline
  • 2Ramantamig · Janssen Research & Development, LLC · next primary completion Sep 2030
  • 2Elranatamab · Pfizer · next primary completion Oct 2030
  • 1Equecabtagene autoleucel · Nanjing IASO Biotechnology Co., Ltd. · next primary completion Aug 2027
  • 1Talquetamab · Janssen Research & Development, LLC
  • 1Pomalidomide · Janssen Research & Development, LLC
Reaching primary completion within a year · 15, 5 in phase 3

Studies that test Bortezomib, phase 3 first.

Studies

Open first, then newest update. How each study uses Bortezomib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 651

See all 651 studies that test Bortezomib →

Given beside what is tested · 195 — Bortezomib is usual care or a partner of the new treatment

Showing 20 of 195.

As the comparator · 33 — what is tested is compared with Bortezomib

Showing 20 of 33.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Bortezomib · ClinicalTrials.gg INT006569

  • MeSH (NLM) D000069286BortezomibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 69G8BD63PPBORTEZOMIBConfirmed FDA, NLM, Wikidata
  • RxNorm 358258Confirmed FDA, Wikidata
  • Wikidata Q419319bortezomibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1851BortezomibOne source FDA
  • DrugBank DB00188One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.